Table 1.
Clinical and pathological characteristics of (A) NSCLC patients, (B) SCLC patients, and (C) healthy donors.
A | |
---|---|
Variable | NSCLC Patients (n = 95) |
Histological subtype | |
Squamous | 34 (35.8) |
Non-squamous | 61 (64.2) |
Stage-n (%) | |
I | 45 (47.4) |
II | 23 (24.2) |
III | 19 (20.0) |
IV | 8 (8.4) |
Gender-n (%) | |
Female | 26 (27.4) |
Male | 69 (72.6) |
Age at diagnostic >75 y/o-n (%) | |
No | 74 (77.9) |
Yes | 21 (22.1) |
Smoking history-n (%) | |
Unknown | 1 (1.1) |
Never | 4 (4.2) |
Ex | 57 (60.0) |
Current | 33 (34.7) |
Pack per year | |
Median | 40 |
Range | 2–107 |
B | |
Variable | SCLC Patients (n = 105) |
Stage-n (%) | |
ED | 69 (65.7) |
LD | 21 (20.0) |
Unknown | 15 (14.3) |
Gender-n (%) | |
Female | 38 (36.2) |
Male | 67 (63.8) |
Age at diagnostic >75 y/o-n (%) | |
No | 78 (74.3) |
Yes | 27 (25.7) |
Smoking history-n (%) | |
Unknown | 10 (9.5) |
Never | 1 (1.0) |
Ex | 32 (30.5) |
Current | 62 (59.0) |
Pack per year | |
Median | 43 |
Range | 1–170 |
C | |
Variable | Healthy Donors (n = 37) |
Gender-n (%) | |
Female | 3 (8.1) |
Male | 34 (91.9) |
Age >75 y/o-n (%) | |
No | 36 (97.3) |
Yes | 1 (2.7) |
Agee (year) | |
Median | 59.5 |
Range | 19−79 |
Smoking history-n (%) | |
Unknown | 19 (51.4) |
Never | 8 (21.6) |
Yes | 10 (27.0) |
Abbreviations: ED, extensive-stage disease; LD, limited-stage disease; NSCLC, non-small-cell lung cancer; SCLC, small-cell lung cancer, y/o: Years old.